It Only Affects Me: Pharmaceutical Regulation and Harm to Others

HEC Forum 34 (3):269-289 (2022)
  Copy   BIBTEX

Abstract

In her Pharmaceutical Freedom, Jessica Flanigan argues that antibiotics can be regulated consistent with her otherwise largely deregulatory view with respect to pharmaceuticals and recreational drugs. I contend in this essay that the reasons for justifying antibiotic regulation are reasons that can be offered to justify the regulation of many other drugs, both pharmaceutical and recreational. After laying out the specifics of Flanigan’s view, I suggest that it is amenable to the regulation of drugs like varenicline. Though such drugs can legitimately improve the quality of a patient’s life by helping them quit smoking, they could be permissibly regulated if they expose others to impermissible risks. I then argue that recreational drugs like alcohol could be regulated using the same reasoning. In the penultimate section of this essay, I anticipate objections that one might have to my extension of arguments favoring antibiotic regulation to drugs correlated with aggression. Flanigan might find my extrapolation of her view as entirely plausible and accept that her view is relatively friendly to these regulations, or she might reconsider her antibiotic caveat if these regulations are overly paternalistic on her understanding. I conclude by briefly considering the benefits and drawbacks of adopting each view.

Links

PhilArchive



    Upload a copy of this work     Papers currently archived: 91,386

External links

Setup an account with your affiliations in order to access resources via your University's proxy server

Through your library

Similar books and articles

Collective Action and Individual Choice.Jonny Anomaly - 2013 - Journal of Medical Ethics 39 (4):752-756.
Big pharma: a story of success in a market economy. [REVIEW]Joao Calinas-Correia - 2013 - Medicine, Health Care and Philosophy 16 (2):305-309.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Intellectual Property and Pharmaceutical Drugs.Richard T. De George - 2005 - Business Ethics Quarterly 15 (4):549-575.
Drugs and Rights.Douglas N. Husak - 1992 - Cambridge University Press.

Analytics

Added to PP
2020-04-11

Downloads
19 (#778,470)

6 months
8 (#342,364)

Historical graph of downloads
How can I increase my downloads?

Author's Profile

Connor K. Kianpour
University of Colorado, Boulder